ASP Isotopes Inc. (NASDAQ:ASPI) Sees Large Increase in Short Interest

ASP Isotopes Inc. (NASDAQ:ASPI) saw a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 1,110,000 shares, an increase of 20.6% from the May 15th total of 920,300 shares. Based on an average trading volume of 789,700 shares, the days-to-cover ratio is presently 1.4 days. Currently, 4.0% of the shares of the stock are short sold.

Analyst Upgrades and Downgrades

Separately, HC Wainwright increased their target price on ASP Isotopes from $5.25 to $5.50 and gave the company a “buy” rating in a research note on Wednesday, April 17th.

Insider Buying and Selling at ASP Isotopes

In other news, Director Robert John Andrew Ryan purchased 9,500 shares of the business’s stock in a transaction dated Thursday, April 25th. The stock was acquired at an average price of $3.42 per share, with a total value of $32,490.00. Following the purchase, the director now directly owns 546,555 shares of the company’s stock, valued at approximately $1,869,218.10. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 26.30% of the stock is owned by corporate insiders.

Institutional Trading of ASP Isotopes

Several institutional investors have recently modified their holdings of the company. HTLF Bank bought a new position in ASP Isotopes in the 4th quarter valued at $141,000. Rathbones Group PLC acquired a new position in shares of ASP Isotopes during the fourth quarter worth about $272,000. Virtu Financial LLC boosted its position in shares of ASP Isotopes by 477.0% during the first quarter. Virtu Financial LLC now owns 83,677 shares of the company’s stock worth $346,000 after buying an additional 69,176 shares during the period. Finally, Vanguard Group Inc. raised its holdings in ASP Isotopes by 479.1% during the first quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock worth $4,217,000 after acquiring an additional 844,705 shares in the last quarter. Institutional investors and hedge funds own 16.80% of the company’s stock.

ASP Isotopes Price Performance

ASPI stock traded down $0.13 during trading hours on Monday, hitting $3.77. 319,734 shares of the stock traded hands, compared to its average volume of 649,212. The company has a current ratio of 3.57, a quick ratio of 3.57 and a debt-to-equity ratio of 1.70. ASP Isotopes has a one year low of $0.38 and a one year high of $5.67. The company has a market cap of $195.14 million, a P/E ratio of -7.00 and a beta of 5.48. The stock has a 50-day simple moving average of $4.01 and a 200 day simple moving average of $3.23.

ASP Isotopes (NASDAQ:ASPI) last posted its quarterly earnings results on Wednesday, May 15th. The company reported ($0.16) earnings per share for the quarter. The firm had revenue of $0.84 million during the quarter. Equities analysts forecast that ASP Isotopes will post -0.11 earnings per share for the current year.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.